A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1994
12/08/1994	CA2164326A1 Cryptic peptides for use in inducing immunologic tolerance
12/08/1994	CA2163887A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis
12/08/1994	CA2163350A1 Opioid receptors: compositions and methods
12/07/1994	EP0626969A1 CoA-IT AND PAF INHIBITORS
12/07/1994	EP0626968A1 Piperidinyl thiacyclic derivatives
12/07/1994	EP0626940A1 Substituted phenylethenyl compounds having retinoid-like biological activity
12/07/1994	EP0626853A1 Use of substituted adenine derivatives for treating multiple sclerosis
12/07/1994	EP0626852A1 Method for making universal donor cells
12/07/1994	EP0626847A1 Histamine derivatives and methods for their use as immunomodulators
12/07/1994	EP0626805A1 Protective effects of mutated superantigens
12/06/1994	USRE34805 Benzonaphthalene derivatives and their use in therapeutic and cosmetic compositions
12/06/1994	US5371204 Interleukins
12/06/1994	US5371093 Antiallergic agent and treats diseases responding to antagonism of 5HT2 receptors
12/06/1994	US5371073 Polypeptide factors from colostrum
12/06/1994	US5370880 Pharmaceutical formulations containing acrivastine
12/06/1994	CA1333397C Fluorinated arachidonic acid derivatives
12/05/1994	CA2125080A1 Peptidic phosphinyloxymethyl ketones as interleukin-1beta-converting enzyme inhibitors
12/04/1994	CA2125021A1 Alpha-heteroaryloxymethyl ketones as interleukin-1 beta converting enzyme inhibitors
12/01/1994	DE4418115A1 Pharmaceutical preparations contg macrolide antibiotics
11/1994
11/30/1994	EP0626390A1 Humanised antibodies
11/30/1994	EP0626389A1 Recombinant antibodies specific for TNF-alpha
11/30/1994	EP0626385A1 Tetrahydropyran derivatives
11/30/1994	EP0626383A1 Palan'amine: a pharmacologically active compound from a sponge
11/30/1994	EP0625990A1 Glycoprotein complexes and glycoproteins
11/30/1994	EP0625983A1 Heterotricyclic derivatives, process for their preparation and pharmaceutical compositions containing them
11/30/1994	EP0625981A1 Azabicyclo compounds as calcium channel antagonists
11/30/1994	EP0625979A1 Azabricyclic compounds as calcium channel antagonists
11/30/1994	EP0625910A1 Dual carrier immunogenic construct
11/30/1994	EP0518904B1 S-(2-thenoyl)-thiolactic acid derivative having pharmacological activity
11/30/1994	EP0422164B1 Large multivalent immunogen
11/30/1994	CN1095720A Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same
11/30/1994	CN1095709A 15-deoxyspergualin analogs, their method of preparation and their use in therapeutics
11/30/1994	CN1095619A Health-care tortoise and soft-shelled turtle capsule and its prepn. method
11/30/1994	CN1026790C 3-\|(5-methyl-2-furanyl) methyl¨-n-(4-piperidinyl)-3H-imidazo\|4,5-B¨-pyridin-2-amine 2-hydroxy-1,2,3-propanetricarboxylate
11/30/1994	CN1026789C Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity
11/29/1994	US5369117 5-(3-formylamino-4-hydroxyphenyl)-3-(1-(4-methoxyphenyl)prop-2-yl)-oxazolidines
11/29/1994	US5369096 Glycolipid derivatives
11/29/1994	US5368865 Suspendible composition and process for preparing the same
11/29/1994	CA1333285C Morpholinoethylester of mycophenolic acid and derivatives thereof
11/29/1994	CA1333257C Use of zinc hydroxide or iron hydroxide as adjuvant in antigen solutions, and antigen solutions containing such adjuvants
11/29/1994	CA1333256C Hyposensitization agent
11/24/1994	WO1994026923A1 Method for recombinant production of biologically active polypeptides
11/24/1994	WO1994026910A1 Immunotoxins comprising gelonin and an antibody
11/24/1994	WO1994026876A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer
11/24/1994	WO1994026786A1 Compositions comprising complement related proteins and carbohydrates, and methods for producing and using said compositions
11/24/1994	WO1994026785A1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
11/24/1994	WO1994026776A1 Therapeutic compounds
11/24/1994	WO1994026773A1 Regulation of antigen presentation
11/24/1994	WO1994026735A1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
11/24/1994	WO1994026725A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
11/24/1994	WO1994026717A1 Hiv protease inhibitors useful for the treatment of aids
11/24/1994	WO1994026707A1 Vitamin d amide derivatives
11/24/1994	WO1994026695A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
11/24/1994	WO1994026307A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	WO1994026293A1 Immunologic enhancement with intermittent interleukin-2 therapy
11/24/1994	WO1994026285A1 Xenograft thymus
11/24/1994	WO1994026284A1 Use of modified tall-104 cells to treat cancer and viral diseases
11/24/1994	WO1994026277A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
11/24/1994	WO1994026272A1 3-[n-(2-mercapto-propionyl-amino-acetyl)]-tetrahydro-thiazolyl-4-carboxylic acid as antiinflammatory and immunostimulating agent
11/24/1994	WO1994026271A1 Treatment of cryptococcus neoformans infection
11/24/1994	WO1994026269A1 Methods and compositions for treating asthma, atherosclerosis andinflammatory diseases using optically pure (-)-zileuton
11/24/1994	WO1994026268A1 Methods and compositions using optically pure (+)-zileuton
11/24/1994	WO1994026266A1 High dose formulations
11/24/1994	WO1994023035A3 Recombinant timothy grass pollen allergen phl p ii
11/24/1994	WO1994022441A3 Use of cis- or transurocanic acid for the treatment of photodermatoses and immunogenic skin diseases
11/24/1994	CA2163219A1 Immunologic enhancement with intermittent interleukin-2 therapy
11/24/1994	CA2162990A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid
11/24/1994	CA2162865A1 Method for recombinant production of biologically active polypeptides
11/24/1994	CA2162853A1 Human t cell monoclone, process for its production and its use, diagnostic of infectious diseases, autoimmune diseases, t-cell mediated allergies and cancer
11/24/1994	CA2162703A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
11/24/1994	CA2162702A1 Novel lupane derivatives, their preparation and pharmaceutical compositions containing same
11/24/1994	CA2162496A1 Allogeneic and xenogeneic transplatation
11/24/1994	CA2162272A1 Vitamin d amide derivatives
11/24/1994	CA2161978A1 Methods and compositions for treating asthma, atherosclerosis and inflammatory diseases using optically pure (-)-zileuton
11/24/1994	CA2161797A1 Xenograft thymus
11/24/1994	CA2161777A1 Methods and compositions using optically pure (+)-zileuton
11/24/1994	CA2161334A1 Hiv protease inhibitors useful in the treatment of aids
11/23/1994	EP0625354A1 Medical preparation containing the subunit p40 of interleukin 12
11/23/1994	EP0625203A1 Synthetic haemophilus influenzae conjugate vaccine
11/23/1994	EP0625201A1 Design, cloning and expression of humanized monoclonal antibodies against human interleukin-5
11/23/1994	EP0625159A1 Ikaros: a t cell pathway regulatory gene
11/23/1994	EP0625150A1 1,3-oxathiolane nucleoside analogues
11/23/1994	EP0625138A1 Novel amidine derivatives, their preparation and their use as mediaments with ltb-4 antagonistic effect
11/23/1994	EP0625053A1 Urease-based vaccine against helicobacter infection
11/23/1994	EP0625051A1 Hepatic growth factor receptor
11/23/1994	EP0549666B1 Novel aminobenzosultam derivatives as lipoxygenase inhibitors
11/23/1994	EP0522013B1 Novel vitamin d analogues
11/23/1994	CN1095383A Substituted 6-azaandrostenones
11/23/1994	CN1095268A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/22/1994	US5367081 Vasodilator, antiallergen
11/22/1994	US5366986 Spirobenzofuran-2(3h)-cycloalkane compounds
11/22/1994	CA1333155C 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents
11/17/1994	EP0624588A1 New quinoline derivatives with pharmacological activity
11/17/1994	EP0624586A1 Substituted pyrroles
11/17/1994	EP0624367A1 Anti-allergic pharmaceutical composition for ophthalmic topical administration comprising an inhibitor of IgE production
11/17/1994	EP0624201A1 Method for producing soluble t-receptors by co-transfection, and use of resulting products
11/17/1994	EP0624200A1 New polypeptides having granulocyte colony stimulating activity, preparation thereof and pharmaceutical compositions containing said polypeptides
11/17/1994	EP0624193A1 Aamp-1, a protein with local homologies to hiv-1 env and nef proteins
11/17/1994	EP0624159A1 Pyridyl substituted imidazoles
11/17/1994	EP0624089A1 Methods

1 ... 1077 1078 1079 1080 1081 1082 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 ... 1172